Discussion-Other non-atherosclerotic causes of myocardial ischaemia

Dr Enrico Cerrato is Consultant Interventional Cardiologist at San Luigi Gonzaga University Hospital and Rivoli Hospital, in Turin, Italy. He completed his training as cardiologist in the Molinette University Hospital (Turin, Italy) and, subsequently, a fellowship in interventional Cardiology at Hospital Clinico San Carlos, Madrid. He is actually completing his PhD program at Universidad Complutense, Madrid. Dr Cerrato has an important track record in the use of meta-analysis as a research tool, an statistical approach he trained under the supervision of Prof. Biondi-Zoccai. Dr Cerrato is one of the founder of CardioGroup (www.cardiogroup.org), a research network that has generated multiple studies on left main PCI, intracoronary physiology, imaging techniques and spontaneous coronary dissection, among many other topics. Dr Cerrato was involved in studies encompassing the use of physiology in complex PCI setting as in left main disease, multiple vessel disease and in the setting of acute coronary syndrome and he is currently co-principal investigator in the PREDICT study which investigates the protective effect of ticagrelor against periprocedural microvascular damage in patients with diabetes.

Enrique Gutiérrez is an Interventional Cardiologist at Hospital Gregorio Marañón, Madrid. After specializing in Cardiology in Zaragoza, he became an interventional cardiologist, and since 2008 he is a Consultant at Gregorio Marañón. He visited Mayo Clinic under the direction of Prof. Amir Lerman, and subsequently started focusing on coronary physiology, with a special interest in microvascular and endothelial function. He has published papers con coronary physiology assessment and the physiology of the non-culprit artery, and is the lead investigator in the Spanish multicenter registry of acetylcholine test ENDOCOR. He is a member of the ESC working group on Coronary Pathophysiology and Microcirculation, and co-chair of the working group for intracoronary diagnosis of the Spanish Association of Interventional Cardiology.

Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. A skilled interventionalist with over 30 years of experience, he regularly serves as live case operator and educationalist in global events like EuroPCR, TCT or the ESC Congress. He is author of over 500 PubMed indexed scientific articles (h-index 71) on topics that include complex PCI in multivessel disease (principal investigator of SYNTAX II study), left main and chronic total occlusions, and secondary revascularization. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Recent / ongoing trials as Co-PI include ADVISE, ADVISE II, DEFINE FLAIR and ABSORB II PHYSIOLOGY, being investigator also in ILUMIEN I and IV, COMBINE and other studies on coronary imaging. He is currently Deputy Editor for Interventional Cardiology of the European Heart Journal, as well as editor of two large textbooks: “Coronary Stenosis.Imaging, Structure and Physiology”, (co-editor Patrick Serruys) and “Physiological Assessment of Coronary Stenoses and the Microcirculation) (co-editor Justin Davies). Current or recent board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Some of his additional interests are philosophy, education and music.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of IFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

Dr Nieves Gonzalo is Consultant Interventional Cardiologist at the Interventional Cardiology Department at Clinico San Carlos University Hospital in Madrid. She obtained her Specialist Certification in Cardiology after training at Clinico San Carlos University Hospital in Madrid. Subsequently, she underwent a research fellowship at Thoraxcenter, Erasmus University Rotterdam (The Netherlands) under the supervision of Professor Patrick Serruys, focused mainly in intracoronary imaging and bioabsorbable stents. In 2010 she obtained her PhD with the thesis “Optical coherence tomography for the assessment of coronary atherosclerosis and vessel response after stent implantation”. Her track record includes over 170 articles indexed in PubMed, as well as book chapters in Interventional Cardiology textbooks. Recent research projects as principal investigator includes a study about the assessment of neoatherosclerosis and its clinical impact in patients with restenosis (RIBS IV and V OCT substudy) and research regarding vessel injury and healing evaluation with different stent platforms evaluated with OCT (VISTA study). Dr Gonzalo is a dedicated educationalist with involvement in many areas of complex PCI, serving currently as Deputy Editor for Eurointervention and Committee Member of EuroPCR.